- Home
- COO vs ARCC Comparison
COO vs ARCC Comparison
Compare COO & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COO
- ARCC
- Stock Information
- Founded
- COO 1980
- ARCC 2004
- Country
- COO United States
- ARCC United States
- Employees
- COO N/A
- ARCC N/A
- Industry
- COO Ophthalmic Goods
- ARCC Finance/Investors Services
- Sector
- COO Health Care
- ARCC Finance
- Exchange
- COO Nasdaq
- ARCC Nasdaq
- Market Cap
- COO 14.6B
- ARCC 15.8B
- IPO Year
- COO N/A
- ARCC 2004
- Fundamental
- Price
- COO $67.15
- ARCC $21.36
- Analyst Decision
- COO Buy
- ARCC Buy
- Analyst Count
- COO 9
- ARCC 9
- Target Price
- COO $80.33
- ARCC $23.00
- AVG Volume (30 Days)
- COO 3.4M
- ARCC 3.7M
- Earning Date
- COO 08-27-2025
- ARCC 10-29-2025
- Dividend Yield
- COO N/A
- ARCC 9.11%
- EPS Growth
- COO 13.33
- ARCC N/A
- EPS
- COO 2.04
- ARCC 2.03
- Revenue
- COO $4,045,700,000.00
- ARCC $3,011,000,000.00
- Revenue This Year
- COO $6.84
- ARCC $3.21
- Revenue Next Year
- COO $6.54
- ARCC $5.09
- P/E Ratio
- COO $31.57
- ARCC $10.37
- Revenue Growth
- COO 6.35
- ARCC 6.85
- 52 Week Low
- COO $61.78
- ARCC $18.26
- 52 Week High
- COO $112.29
- ARCC $23.84
- Technical
- Relative Strength Index (RSI)
- COO 44.39
- ARCC 33.94
- Support Level
- COO $64.19
- ARCC $21.02
- Resistance Level
- COO $68.73
- ARCC $22.50
- Average True Range (ATR)
- COO 1.73
- ARCC 0.27
- MACD
- COO -0.21
- ARCC -0.12
- Stochastic Oscillator
- COO 47.15
- ARCC 28.53
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
About ARCC Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.